Molecular aspects of regulatory T cell development

Seminars in Immunology

Volumn 16, Issue 2, 2004, Pages 73-80

  Fontenot, Jason D ^a   Rudensky, Alexander Y ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

CD4+ regulatory T cells; Foxp3; IL 2; Immune tolerance; T cell development

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2;

CELL LINEAGE; CELL MATURATION; GENE MUTATION; IMMUNOREGULATION; MOLECULAR DYNAMICS; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 1242317790     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2003.12.002     Document Type: Article

References (64)

1. Shevach E.M. Regulatory T cells in autoimmmunity. Annu. Rev. Immunol. 18:2000;423.
2. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1995;1151.
3. Shevach E.M. CD4+ CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:2002;389.
4. Itoh M., Takahashi T., Sakaguchi N., Kuniyasu Y., Shimizu J., Otsuka F. et al. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162:1999;5317.
5. Papiernik M., de Moraes M.L., Pontoux C., Vasseur F., Penit C. Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int. Immunol. 10:1998;371.
6. Papiernik M., do Carmo Leite-de-Moraes M., Pontoux C., Joret A.M., Rocha B., Penit C.et al. T cell deletion induced by chronic infection with mouse mammary tumor virus spares a CD25-positive, IL-10-producing T cell population with infectious capacity. J. Immunol. 158:1997;4642.
7. Jordan M.S., Boesteanu A., Reed A.J., Petrone A.L., Holenbeck A.E., Lerman M.A., Naji A., Caton A.J. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2:2001;301.
8. Apostolou I., Sarukhan A., Klein L., von Boehmer H. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3:2002;756.
9. Klein L., Khazaie K., von Boehmer H. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. U.S.A. 100:2003;8886.
10. Walker L.S., Chodos A., Eggena M., Dooms H., Abbas A.K. Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J. Exp. Med. 198:2003;249.
11. Bensinger S.J., Bandeira A., Jordan M.S., Caton A.J., Laufer T.M. Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells. J. Exp. Med. 194:2001;427.
12. Cozzo C., Larkin J., Caton A.J. 3rd Self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells. J. Immunol. 171:2003;5678.
13. Buhlmann J.E., Elkin S.K., Sharpe A.H. A role for the B7-1/B7-2:CD28/CTLA-4 pathway during negative selection. J. Immunol. 170:2003;5421.
14. Tang Q., Henriksen K.J., Boden E.K., Tooley A.J., Ye J., Subudhi S.K.et al. Cutting edge: CD28 controls peripheral homeostasis of CD4+ CD25+ regulatory T cells. J. Immunol. 171:2003;3348.
15. Salomon B., Lenschow D.J., Rhee L., Ashourian N., Singh B., Sharpe A.et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity. 12:2000;431.
16. Takahashi T., Tagami T., Yamazaki S., Uede T., Shimizu J., Sakaguchi N. et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192:2000;303.
17. Waterhouse P., Penninger J.M., Timms E., Wakeham A., Shahinian A., Lee K.P.et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science. 270:1995;985.
18. Tivol E.A., Borriello F., Schweitzer A.N., Lynch W.P., Bluestone J.A., Sharpe A.H. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 3:1995;541.
19. Egen J.G., Kuhns M.S., Allison J.P. CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat. Immunol. 3:2002;611.
20. Tivol E.A., Gorski J. Re-establishing peripheral tolerance in the absence of CTLA-4: complementation by wild-type T cells points to an indirect role for CTLA-4. J. Immunol. 169:2002;1852.
21. Bachmann M.F., Gallimore A., Jones E., Ecabert B., Acha-Orbea H., Kopf M. Normal pathogen-specific immune responses mounted by CTLA-4-deficient T cells: a paradigm reconsidered. Eur. J. Immunol. 31:2001;450.
22. Bachmann M.F., Kohler G., Ecabert B., Mak T.W., Kopf M. Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J. Immunol. 163:1999;1128.
23. Chambers C.A., Sullivan T.J., Truong T., Allison J.P. Secondary but not primary T cell responses are enhanced in CTLA-4-deficient CD8+ T cells. Eur. J. Immunol. 28:1998;3137.
24. Bachmann M.F., Waterhouse P., Speiser D.E., McKall-Faienza K., Mak T.W., Ohashi P.S. Normal responsiveness of CTLA-4-deficient anti-viral cytotoxic T cells. J. Immunol. 160:1998;95.
25. Read S., Malmstrom V., Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 192:2000;295.
26. Jonuleit H., Schmitt E., Stassen M., Tuettenberg A., Knop J., Enk A.H. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193:2001;1285.
27. Levings M.K., Sangregorio R., Roncarolo M.G. Human CD25(+)CD4(+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193:2001;1295.
28. Thornton A.M., Shevach E.M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:1998;287.
29. Nelson B.H., Willerford D.M. Biology of the interleukin-2 receptor. Adv. Immunol. 70:1998;1.
30. Sadlack B., Lohler J., Schorle H., Klebb G., Haber H., Sickel E.et al. Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. Eur. J. Immunol. 25:1995;3053.
31. Sadlack B., Merz H., Schorle H., Schimpl A., Feller A.C., Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 75:1993;253.
32. Suzuki H., Kundig T.M., Furlonger C., Wakeham A., Timms E., Matsuyama T.et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science. 268:1995;1472.
33. Willerford D.M., Chen J., Ferry J.A., Davidson L., Ma A., Alt F.W. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity. 3:1995;521.
34. Van Parijs L., Biuckians A., Ibragimov A., Alt F.W., Willerford D.M., Abbas A.K. Functional responses and apoptosis of CD25 (IL-2R alpha)-deficient T cells expressing a transgenic antigen receptor. J. Immunol. 158:1997;3738.
35. Lenardo M.J. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature. 353:1991;858.
36. Suzuki H., Zhou Y.W., Kato M., Mak T.W., Nakashima I. Normal regulatory alpha/beta T cells effectively eliminate abnormally activated T cells lacking the interleukin 2 receptor beta in vivo. J. Exp. Med. 190:1999;1561.
37. Leung D.T., Morefield S., Willerford D.M. Regulation of lymphoid homeostasis by IL-2 receptor signals in vivo. J. Immunol. 164:2000;3527.
38. Malek T.R., Yu A., Vincek V., Scibelli P., Kong L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity. 17:2002;167.
39. Malek T.R., Porter B.O., Codias E.K., Scibelli P., Yu A. Normal lymphoid homeostasis and lack of lethal autoimmunity in mice containing mature T cells with severely impaired IL-2 receptors. J. Immunol. 164:2000;2905.
40. Wolf M., Schimpl A., Hunig T. Control of T cell hyperactivation in IL-2-deficient mice by CD4(+)CD25(-) and CD4(+)CD25(+) T cells: evidence for two distinct regulatory mechanisms. Eur. J. Immunol. 31:2001;1637.
41. Almeida A.R., Legrand N., Papiernik M., Freitas A.A. Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J. Immunol. 169:2002;4850.
42. Furtado G.C., Curotto de Lafaille M.A., Kutchukhidze N., Lafaille J.J. Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J. Exp. Med. 196:2002;851.
43. Antov A., Yang L., Vig M., Baltimore D., Van Parijs L. Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance. J. Immunol. 171:2003;3435.
44. McHugh R.S., Whitters M.J., Piccirillo C.A., Young D.A., Shevach E.M., Collins M.et al. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity. 16:2002;311.
45. Shimizu J., Yamazaki S., Takahashi T., Ishida Y., Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3:2002;135.
46. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4:2003;330.
47. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 299:2003;1057.
48. Khattri R., Cox T., Yasayko S.A., Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4:2003;337.
49. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A.et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27:2001;68.
50. Wildin R.S., Ramsdell F., Peake J., Faravelli F., Casanova J.L., Buist N.et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27:2001;18.
51. Chatila T.A., Blaeser F., Ho N., Lederman H.M., Voulgaropoulos C., Helms C.et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 106:2000;R75.
52. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L.et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27:2001;20.
53. Gambineri E., Torgerson T.R., Ochs H.D. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr. Opin. Rheumatol. 15:2003;430.
54. Godfrey V.L., Wilkinson J.E., Rinchik E.M., Russell L.B. Fatal lymphoreticular disease in the scurfy (sf) mouse requires T cells that mature in a sf thymic environment: potential model for thymic education. Proc. Natl. Acad. Sci. U.S.A. 88:1991;5528.
55. Godfrey V.L., Rouse B.T., Wilkinson J.E. Transplantation of T cell-mediated, lymphoreticular disease from the scurfy (sf) mouse. Am. J. Pathol. 145:1994;281.
56. Clark L.B., Appleby M.W., Brunkow E., Wilkinson J.E., Ziegler S.F., Ramsdell F. Cellular and molecular characterization of the scurfy mouse mutant. J. Immunol. 162:1999;2546.
57. - T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse. J. Immunol. 153:1994;3764.
58. Zahorsky-Reeves J.L., Wilkinson J.E. The murine mutation scurfy (sf) results in an antigen-dependent lymphoproliferative disease with altered T cell sensitivity. Eur. J. Immunol. 31:2001;196.
59. Schubert L.A., Jeffery E., Zhang Y., Ramsdell F., Ziegler S.F. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 276:2001;37672.
60. Tommasini A., Ferrari S., Moratto D., Badolato R., Boniotto M., Pirulli D.et al. X-chromosome inactivation analysis in a female carrier of FOXP3 mutation. Clin. Exp. Immunol. 130:2002;127.
61. Hernandez-Hoyos G., Sohn S.J., Rothenberg E.V., Alberola-Ila J. Lck activity controls CD4/CD8 T cell lineage commitment. Immunity. 12:2000;313.
62. Basson M.A., Bommhardt U., Mee P.J., Tybulewicz V.L., Zamoyska R. Molecular requirements for lineage commitment in the thymus - antibody-mediated receptor engagements reveal a central role for lck in lineage decisions. Immunol. Rev. 165:1998;181.
63. Thorstenson K.M., Khoruts A. Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J. Immunol. 167:2001;188.
64. Jooss K., Gjata B., Danos O., von Boehmer H., Sarukhan A. Regulatory function of in vivo anergized CD4(+) T cells. Proc. Natl. Acad. Sci. U.S.A. 98:2001;8738.